Leidos Australia and Aspen Medical Join Forces to Deliver the Next Generation of Defence Health Capability
CANBERRA, Australia (28 OCT 2025) – Leidos Australia and Aspen Medical have entered into a strategic partnership to bid for the Australian Defence Contracted Health System (ADCHS) program — a significant opportunity to redefine how healthcare supports the readiness of Australia’s Defence Force (ADF).
Together, Leidos and Aspen Medical are seeking to deliver an integrated, mission-focused care model, that includes primary and specialist medical services, mental health support and occupational rehabilitation for ADF personnel.
Under the partnership, Aspen Medical will provide support as a health service delivery partner, supplementing and expanding Leidos’ own existing Defence knowledge, strength and experience in the successful delivery of programs for the ADF as well as internationally for the Australian Government.
By combining Leidos’ global expertise in health, logistics and systems integration with Aspen Medical’s deep clinical capability and nationwide delivery network, the partnership will aim to deliver a truly integrated model that makes health a core component of Defence capability, not just a service.
Leidos Australia Chief Executive Paul Chase said the partnership will seek to transform how health services contribute to Defence readiness.
“Our mission is to deliver more than healthcare. Our goal is to build a nationwide, technology-enabled system that keeps Defence’s most important capability, its people, mission-ready at all times,” Mr Chase said. “This opportunity aligns with our NorthStar 2030 strategy, supporting our continued growth in the managed health services sector.”
“With the uncertainty Australia is facing, surge capacity and flexibility for Defence Health has never been more important. Together, we can help Defence build a sustainable health system that’s fit for the future force.”
Aspen Medical Group Chief Executive Officer, Craig Fitzgerald said, “Aspen Medical has been a trusted provider of contracted health services to the ADF and defence forces around the world for more than two decades. We’re incredibly pleased to be partnering with Leidos Australia to bid for this essential Defence service contract. We believe our collective understanding of Defence’s healthcare needs, Australia’s strategic landscape, and our proven ability to deliver high-quality care at scale positions us as a trusted partner in supporting the ADF’s health capability.”
About Leidos
Leidos is an industry and technology leader serving government and commercial customers with smarter, more efficient digital and mission innovations. Leidos Australia is a trusted partner to the Australian Government, leveraging global experience and a network of partners to deliver solutions that support intelligence, defence, aviation, border protection, and health markets while protecting and improving the Australian way of life. Headquartered in Reston, Virginia, with 47,000 global employees, Leidos reported annual revenues of approximately $16.7 billion for the fiscal year ended January 3, 2025. For more information, visit www.leidos.com
About Aspen
Aspen Medical is an Australian and veteran-owned global healthcare company that delivers comprehensive solutions across the full spectrum of health services, infrastructure and technology in some of the world’s most challenging environments. Headquartered in Canberra, Aspen Medical operates across 23 countries and is a trusted partner to governments, defence forces, and humanitarian organisations worldwide. For more information visit www.aspenmedical.com.
Certain statements in this announcement constitute “forward-looking statements” within the meaning of the rules and regulations of the U.S. Securities and Exchange Commission (SEC). These statements are based on management’s current beliefs and expectations and are subject to significant risks and uncertainties. These statements are not guarantees of future results or occurrences. A number of factors could cause our actual results, performance, achievements, or industry results to be different from the results, performance, or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, the “Risk Factors” set forth in Leidos’ Annual Report on Form 10-K for the fiscal year ended January 3, 2025, and other such filings that Leidos makes with the SEC from time to time. Readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. Leidos does not undertake to update forward-looking statements to reflect the impact of circumstances or events that arise after the date the forward-looking statements were made.
